AVENUE THERAPEUTICS INC's ticker is ATXI and the CUSIP is 05360L205. A total of 15 filers reported holding AVENUE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -42.9% | 13,767 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -46.2% | 13,767 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -38.1% | 13,767 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -40.0% | 13,767 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -92.5% | 13,767 | -82.1% | 0.00% | – |
| Q1 2021 | $467,000 | -5.1% | 77,049 | -6.8% | 0.00% | – |
| Q4 2020 | $492,000 | -43.9% | 82,691 | +2.1% | 0.00% | – |
| Q3 2020 | $877,000 | +162.6% | 80,965 | +161.3% | 0.00% | – |
| Q2 2020 | $334,000 | +156.9% | 30,989 | +112.7% | 0.00% | – |
| Q1 2020 | $130,000 | -7.1% | 14,568 | 0.0% | 0.00% | – |
| Q4 2019 | $140,000 | +60.9% | 14,568 | 0.0% | 0.00% | – |
| Q3 2019 | $87,000 | -5.4% | 14,568 | 0.0% | 0.00% | – |
| Q2 2019 | $92,000 | +33.3% | 14,568 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | -12.7% | 14,568 | 0.0% | 0.00% | – |
| Q4 2018 | $79,000 | – | 14,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 800,000 | $3,800,000 | 1.05% |
| EAM Investors, LLC | 91,966 | $437,000 | 0.11% |
| B. Riley Wealth Advisors, Inc. | 59,250 | $282,000 | 0.04% |
| Frontier Wealth Management LLC | 20,000 | $95,000 | 0.01% |
| Spark Investment Management LLC | 30,500 | $144,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 4,785 | $23,000 | 0.00% |
| BlackRock Inc. | 16,939 | $80,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 408 | $2,000 | 0.00% |
| DEUTSCHE BANK AG\ | 10,808 | $51,000 | 0.00% |